The first human trial operation of domestic Agibot® endoscopic robot:3 cases report
Xu Linfeng
Liu Guangxiang
Zhang Shun
Guo Hongqian
Abstract：3 patients who enrolled in the human clinical trial of domestic Agibot® endoscopic robot in December 2023 were retrospectively analyzed in our hospital.All patients were male,including 2 cases of prostate cancer and 1 case of renal cell carcinoma.The patients ranged in age from 44.8 to 75.4 years,including 2 cases of radical prostatec-tomy(subject number Y01001,Y01002)and 1 case of partial nephrectomy(subject number Y01003).All operations were successfully completed without conversion to open or conventional laparoscopic surgery.There were none intra-operative or immediate postoperative complications,and none blood transfusions were required.In 2 cases of radical prostatectomy,the pre-docking time ranged from 4 to 8 minutes,with a surgical duration of 132 to 141 minutes,drain removal after 3 days,and postoperative hospital stay of 3 to 5 days,the postoperative pathological diagnoses were prostate adenocarcinoma,and the prostate specific antigen(PSA)was<0.1 μg/L at 30 days after surgery.In 1 case of partial nephrectomy,the pre-docking timewas 6 minutes,surgical duration was 87 minutes,warm ischemia time was 24 minutes,drain removal after 3 days,and postoperative hospital stay of 7 days,the postoperative patho-logical diagnosis was clear cell renal cell carcinoma with negative surgical margin.Intraoperative indexes and postoper-ative results showed that the domestic Agibot® endoscopic robot had a good effect and the patient recovered smooth-ly.Long-term effects need to be further verified by large sample,multi-center,long-term follow-up studies.
Keywords：Agibot®laparoscopic surgical robotrobotic surgeryradical prostatectomypartial nephrectomyhuman clinical trial
Publication Date：2024-02-05
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 1-6 )